2016 December
Safety and Efficacy of Combination Targeted Therapy and Radiotherapy
March 9th 2017ArticleClinical Articles
A review of currently published clinical trials examining the combinaiton of radiation therapy with commonly used targeted agents, such as vascular endothelial growth factor inhibitors, endothelial growth factor receptor inhibitors, and inhibitors of the PI3K/Akt/mTOR pathway.
Neoadjuvant Nivolumab/Ipilimumab Shows Early Promise for Stage III Melanoma
January 23rd 2017ArticleClinical Articles
Neoadjuvant therapy with the combination of nivolumab and ipilimumab is plausible and effective, but can induce a high level of adverse events calling for further research into better tolerated dosing schemes.
